These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35388959)

  • 41. Disrupted structural and functional brain connectomes in mild cognitive impairment and Alzheimer's disease.
    Dai Z; He Y
    Neurosci Bull; 2014 Apr; 30(2):217-32. PubMed ID: 24733652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of Graph Theory Applied to EEG Data Analysis for Alzheimer's Disease Versus Vascular Dementia Diagnosis.
    Vecchio F; Miraglia F; Alú F; Orticoni A; Judica E; Cotelli M; Rossini PM
    J Alzheimers Dis; 2021; 82(2):871-879. PubMed ID: 34092648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biomarker Extraction Based on Subspace Learning for the Prediction of Mild Cognitive Impairment Conversion.
    Li Y; Fang Y; Wang J; Zhang H; Hu B
    Biomed Res Int; 2021; 2021():5531940. PubMed ID: 34513992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Machine Learning-based Approaches to Predict the Conversion to Alzheimer's Disease from Mild Cognitive Impairment.
    Franciotti R; Nardini D; Russo M; Onofrj M; Sensi SL; ;
    Neuroscience; 2023 Mar; 514():143-152. PubMed ID: 36736612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
    J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
    Li J; Bur AM; Villwock MR; Shankar S; Palmer G; Sykes KJ; Villwock JA
    J Alzheimers Dis; 2021; 81(2):641-650. PubMed ID: 33843686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early diagnosis of Alzheimer's disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts.
    Rossini PM; Di Iorio R; Vecchio F; Anfossi M; Babiloni C; Bozzali M; Bruni AC; Cappa SF; Escudero J; Fraga FJ; Giannakopoulos P; Guntekin B; Logroscino G; Marra C; Miraglia F; Panza F; Tecchio F; Pascual-Leone A; Dubois B
    Clin Neurophysiol; 2020 Jun; 131(6):1287-1310. PubMed ID: 32302946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    van de Mortel LA; Thomas RM; van Wingen GA;
    J Alzheimers Dis; 2021; 83(2):705-720. PubMed ID: 34366336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review on Alzheimer's disease classification from normal controls and mild cognitive impairment using structural MR images.
    Garg N; Choudhry MS; Bodade RM
    J Neurosci Methods; 2023 Jan; 384():109745. PubMed ID: 36395961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.
    Guo LH; Alexopoulos P; Eisele T; Wagenpfeil S; Kurz A; Perneczky R
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):325-33. PubMed ID: 22932720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
    Drago V; Babiloni C; Bartrés-Faz D; Caroli A; Bosch B; Hensch T; Didic M; Klafki HW; Pievani M; Jovicich J; Venturi L; Spitzer P; Vecchio F; Schoenknecht P; Wiltfang J; Redolfi A; Forloni G; Blin O; Irving E; Davis C; Hårdemark HG; Frisoni GB
    J Alzheimers Dis; 2011; 26 Suppl 3():159-99. PubMed ID: 21971460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain neural synchronization and functional coupling in Alzheimer's disease as revealed by resting state EEG rhythms.
    Babiloni C; Lizio R; Marzano N; Capotosto P; Soricelli A; Triggiani AI; Cordone S; Gesualdo L; Del Percio C
    Int J Psychophysiol; 2016 May; 103():88-102. PubMed ID: 25660305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A survey on applications and analysis methods of functional magnetic resonance imaging for Alzheimer's disease.
    Forouzannezhad P; Abbaspour A; Fang C; Cabrerizo M; Loewenstein D; Duara R; Adjouadi M
    J Neurosci Methods; 2019 Apr; 317():121-140. PubMed ID: 30593787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
    Beheshti I; Demirel H; Matsuda H;
    Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases.
    Popuri K; Ma D; Wang L; Beg MF
    Hum Brain Mapp; 2020 Oct; 41(14):4127-4147. PubMed ID: 32614505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.